1.89
Alector Inc stock is traded at $1.89, with a volume of 1.20M.
It is down -1.05% in the last 24 hours and up +24.34% over the past month.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
See More
Previous Close:
$1.91
Open:
$1.87
24h Volume:
1.20M
Relative Volume:
0.74
Market Cap:
$206.30M
Revenue:
$100.56M
Net Income/Loss:
$-119.05M
P/E Ratio:
-1.5366
EPS:
-1.23
Net Cash Flow:
$-231.16M
1W Performance:
-2.58%
1M Performance:
+24.34%
6M Performance:
+18.12%
1Y Performance:
+9.88%
Alector Inc Stock (ALEC) Company Profile
Name
Alector Inc
Sector
Industry
Phone
415-231-5660
Address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Compare ALEC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ALEC
Alector Inc
|
1.89 | 208.48M | 100.56M | -119.05M | -231.16M | -1.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.90 | 120.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.45 | 78.77B | 14.34B | 4.50B | 3.88B | 41.57 |
|
ARGX
Argen X Se Adr
|
840.50 | 52.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
338.06 | 45.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
340.38 | 38.73B | 4.98B | 69.59M | 525.67M | 0.5197 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-22-25 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-22-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-22-25 | Downgrade | Mizuho | Outperform → Neutral |
| Oct-22-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-22-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-28-25 | Upgrade | Mizuho | Neutral → Outperform |
| Dec-17-24 | Downgrade | Mizuho | Outperform → Neutral |
| Dec-16-24 | Downgrade | Stifel | Buy → Hold |
| Dec-04-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Nov-29-24 | Reiterated | H.C. Wainwright | Buy |
| Nov-26-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Dec-14-23 | Upgrade | Stifel | Hold → Buy |
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Sep-25-23 | Initiated | Goldman | Sell |
| Sep-22-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-06-23 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-09-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-07-22 | Initiated | Mizuho | Buy |
| Apr-13-22 | Initiated | Goldman | Sell |
| Mar-08-22 | Downgrade | Stifel | Buy → Hold |
| Sep-27-21 | Initiated | William Blair | Outperform |
| Jan-15-21 | Resumed | BofA Securities | Buy |
| Jun-24-20 | Initiated | H.C. Wainwright | Buy |
| Apr-28-20 | Initiated | Goldman | Buy |
| Mar-06-20 | Initiated | Citigroup | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Feb-19-20 | Initiated | Stifel | Buy |
| Nov-21-19 | Initiated | BTIG Research | Buy |
| Mar-04-19 | Initiated | Barclays | Overweight |
| Mar-04-19 | Initiated | BofA/Merrill | Buy |
| Mar-04-19 | Initiated | Morgan Stanley | Overweight |
| Mar-04-19 | Initiated | SVB Leerink | Outperform |
View All
Alector Inc Stock (ALEC) Latest News
Legal Scrutiny Adds to Alector’s Clinical Setback Challenges - AD HOC NEWS
Panic Selling: Is NEXGEL Inc Equity Warrant benefiting from innovation trends2025 Technical Overview & Target Return Focused Picks - baoquankhu1.vn
INVESTOR ALERT: Levi & Korsinsky is Investigating Alec Stock After its Phase 3 INFRONT-3 Clinical Trial Misses Co-Primary Endpoint - The Malaysian Reserve
Levi & Korsinsky is Investigating Alec Stock After its Phase 3 INFRONT-3 Clinical Trial Misses Co-Primary Endpoint - marketscreener.com
Alector, Inc. (NASDAQ:ALEC) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
There's No Escaping Alector, Inc.'s (NASDAQ:ALEC) Muted Revenues Despite A 32% Share Price Rise - simplywall.st
Looking At The Narrative For Alector (ALEC) After Latozinemab Setback And Cost Cuts - Yahoo Finance
4 Next-Gen Candidates That Could Form the Future of Alzheimer’s Treatment - BioSpace
Take Profit: Is Alector Inc a strong growth stockWeekly Market Summary & AI Forecasted Stock Moves - baoquankhu1.vn
Price Action: Is Alector Inc stock positioned for digital transformationWeekly Trading Summary & AI Powered Market Entry Strategies - Bộ Nội Vụ
Aug PostEarnings: Will Alector Inc. (0Z2) stock profit from automation wave2025 Investor Takeaways & AI Forecast Swing Trade Picks - Bộ Nội Vụ
Merger Talk: Is BRKB showing insider buyingLayoff News & Real-Time Stock Entry Alerts - baoquankhu1.vn
Published on: 2026-01-11 01:48:35 - ulpravda.ru
How rising interest rates impact Alector Inc. stock2025 EndofYear Setup & Growth Focused Investment Plans - ulpravda.ru
What insider trading reveals about Alector Inc. stockRetail Investor Activity & Low Cost Stock Ideas - bollywoodhelpline.com
Will Alector Inc. (0Z2) stock profit from automation waveMarket Volume Summary & Technical Buy Zone Confirmation - ulpravda.ru
Guidance Update: How institutional buying supports Alector Inc. stockJuly 2025 Review & Free High Return Stock Watch Alerts - Улправда
How institutional buying supports Alector Inc. stockRecession Risk & Weekly Top Gainers Trade List - Улправда
Will Alector Inc. stock split again soonWeekly Trade Recap & AI Optimized Trading Strategy Guides - Улправда
Levi & Korsinsky Announces an Investigation on Behalf of Alector, Inc. (ALEC) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire
Alector (NASDAQ:ALEC) Stock Rating Upgraded by BTIG Research - MarketBeat
Alector : January 2026 Corporate Presentation - marketscreener.com
Rockford Register Star: Local News, Politics & Sports in Rockford, IL - FinancialContent
Alector, Inc. (ALEC) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - ACCESS Newswire
Setup Watch: Will Sound Group Inc Depositary Receipt stock see PE expansion2025 Technical Patterns & Smart Allocation Stock Tips - moha.gov.vn
ALEC ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Alector, Inc. - ACCESS Newswire
Alector, Inc. (NASDAQ:ALEC) Given Average Rating of "Reduce" by Analysts - MarketBeat
Investors who lost money on Alector, Inc. should contact Levi & Korsinsky about an ongoing investigationALEC - ACCESS Newswire
Short Interest in Alector, Inc. (NASDAQ:ALEC) Expands By 35.9% - MarketBeat
Alector (NASDAQ:ALEC) Trading 4.8% HigherHere's Why - MarketBeat
Alector, Inc. Investigated Regarding Potential Securities Law ViolationsContact Levi & Korsinsky for DetailsALEC - ACCESS Newswire
Shareholder Rights Advocates at Levi & Korsinsky Investigate Alector, Inc. (ALEC) Regarding Possible Securities Fraud Violations - ACCESS Newswire
Is Alector Inc a good long term investmentInterest Rate Changes & Affordable Trading Techniques - earlytimes.in
Alector, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud AllegationsALEC - ACCESS Newswire
Is Alector Inc. stock attractive for hedge fundsJuly 2025 Big Picture & AI Optimized Trading Strategy Guides - Улправда
What catalysts could drive Alector Inc. stock higherMarket Growth Review & AI Powered Trade Plan Recommendations - Улправда
Profit Review: How rising interest rates impact Alector Inc. stockShort Setup & Reliable Volume Spike Trade Alerts - Улправда
Alector appoints Neil Berkley as chief financial officer - MSN
Hedge Fund Bets: Can Alector Inc. stock sustain free cash flow growth2025 Stock Rankings & Reliable Entry Point Trade Alerts - Улправда
Will Alector Inc. stock outperform tech sector in 2025CEO Change & Daily Technical Forecast Reports - Улправда
Shareholders that lost money on Alector, Inc.(ALEC) should contact Levi & Korsinsky about Securities Fraud InvestigationALEC - ACCESS Newswire
Will Alector Inc. stock reach Wall Street targetsPortfolio Performance Report & High Conviction Buy Zone Alerts - DonanımHaber
Can Alector Inc. (0Z2) stock deliver strong annual returnsJuly 2025 Drop Watch & Smart Allocation Stock Tips - DonanımHaber
Is Alector Inc. stock a top momentum play2025 Bull vs Bear & Daily Technical Stock Forecast Reports - DonanımHaber
Options Flow: What catalysts could drive Alector Inc. stock higherJuly 2025 Summary & Expert-Curated Trade Recommendations - Улправда
Will Alector Inc. stock reach all time highs in 2025Bond Market & Fast Moving Stock Trade Plans - DonanımHaber
Can Alector Inc. stock sustain free cash flow growthFed Meeting & Free Weekly Watchlist of Top Performers - Улправда
Will Alector Inc. stock deliver long term returnsJuly 2025 Technicals & Low Risk Growth Stock Ideas - Улправда
Alector, Inc.(NasdaqGS: ALEC) dropped from NASDAQ Biotechnology Index - marketscreener.com
Investigation Alert: Alector, Inc. (ALEC) Under ScrutinyContact Levi & Korsinsky For Details - ACCESS Newswire
Alector Earnings Notes - Trefis
Alector Inc Stock (ALEC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):